Company Optimind Pharma Corp. OTC Markets
Equities
LOONF
CA68405U1012
Biotechnology & Medical Research
Business Summary
Sales per Business
CAD in Million | 2023 | Weight | Delta |
---|---|---|---|
Ketamine and Cannabis Referrals
100.0
%
| 0 | 100.0 % | - |
Sales per region
CAD in Million | 2023 | Weight | Delta |
---|---|---|---|
Canada
100.0
%
| 0 | 100.0 % | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 116,888,491 | 107,900,586 ( 92.31 %) | 0 | 92.31 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |